Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) FCF Margin (2016 - 2025)

Medifast (MED) has disclosed FCF Margin for 16 consecutive years, with 8.83% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 275.0% year-over-year to 8.83%, compared with a TTM value of 0.32% through Dec 2025, down 250.0%, and an annual FY2025 reading of 0.32%, down 250.0% over the prior year.
  • FCF Margin was 8.83% for Q4 2025 at Medifast, down from 12.02% in the prior quarter.
  • Across five years, FCF Margin topped out at 17.83% in Q1 2021 and bottomed at 8.83% in Q4 2025.
  • Average FCF Margin over 5 years is 6.04%, with a median of 6.04% recorded in 2024.
  • The sharpest move saw FCF Margin tumbled -2264bps in 2021, then soared 1770bps in 2022.
  • Year by year, FCF Margin stood at 5.05% in 2021, then surged by 351bps to 12.65% in 2022, then tumbled by -60bps to 5.01% in 2023, then plummeted by -221bps to 6.08% in 2024, then plummeted by -45bps to 8.83% in 2025.
  • Business Quant data shows FCF Margin for MED at 8.83% in Q4 2025, 12.02% in Q3 2025, and 4.51% in Q2 2025.